Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists
Francesco Prattichizzo, Paola de Candia, Antonio Ceriello
Metabolism (2021) Vol. 120, pp. 154799-154799
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Yiwen Li, Yanfei Liu, Shiwei Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 239
Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
Agata Winiarska, Monika Knysak, Katarzyna Nabrdalik, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10822-10822
Open Access | Times Cited: 124
Pharmacotherapy of type 2 diabetes: An update and future directions
Antea DeMarsilis, Niyoti Reddy, Chrysoula Boutari, et al.
Metabolism (2022) Vol. 137, pp. 155332-155332
Closed Access | Times Cited: 95
Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin
Rosalba La Grotta, Paola de Candia, Fabiola Olivieri, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 5
Open Access | Times Cited: 81
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes
Raffaele Marfella, Celestino Sardu, Nunzia D’Onofrio, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 52
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes
Raffaele Marfella, Francesco Prattichizzo, Celestino Sardu, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Repurposing SGLT-2 Inhibitors to Target Aging: Available Evidence and Molecular Mechanisms
Rosalba La Grotta, Chiara Frigé, Giulia Matacchione, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12325-12325
Open Access | Times Cited: 38
Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging
Ema Schönberger, Vjera Mihaljević, Kristina Steiner, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 17, pp. 6671-6671
Open Access | Times Cited: 28
The legacy effect of hyperglycemia and early use of SGLT-2 inhibitors: a cohort study with newly-diagnosed people with type 2 diabetes
Antonio Ceriello, Giuseppe Lucisano, Francesco Prattichizzo, et al.
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100666-100666
Open Access | Times Cited: 22
Application of Luteolin in Neoplasms and Nonneoplastic Diseases
Katarzyna Rakoczy, Justyna Kaczor, Adam Sołtyk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15995-15995
Open Access | Times Cited: 22
Pharmacological functions of salidroside in renal diseases: facts and perspectives
Qiong Liu, Jianzhu Chen, Anqi Zeng, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 12
Organ-specific biological clocks: Ageotyping for personalized anti-aging medicine
Francesco Prattichizzo, Chiara Frigé, Valeria Pellegrini, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102253-102253
Open Access | Times Cited: 12
Advances in secondary prevention mechanisms of macrovascular complications in type 2 diabetes mellitus patients: a comprehensive review
Huifang Guan, Jiaxing Tian, Ying Wang, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 6
The Interplay of Autophagy and Oxidative Stress in the Kidney: What Do We Know?
Haihua Guo, Wibke Bechtel‐Walz
˜The œNephron journals/Nephron journals (2023) Vol. 147, Iss. 10, pp. 627-642
Closed Access | Times Cited: 15
Prescription of glucagon-like peptide 1 agonists and risk of subsequent open-angle glaucoma in individuals with type 2 diabetes mellitus
Chih‐Chun Chuang, Kai Wang, Chao‐Kai Chang, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 3, pp. 540-546
Open Access | Times Cited: 5
Comparing the effects of empagliflozin and liraglutide on lipid metabolism and intestinal microflora in diabetic mice
Qiong Yang, Ling Deng, Changmei Feng, et al.
PeerJ (2024) Vol. 12, pp. e17055-e17055
Open Access | Times Cited: 5
Novel Biomarkers for the diagnosis of diabetic nephropathy.
Marcio Concepción, Juan Carlos Quiroz, Jacsel Suárez, et al.
PubMed (2024) Vol. 15, Iss. 3, pp. 382-391
Closed Access | Times Cited: 5
Inflammatory Trajectory of Type 2 Diabetes: Novel Opportunities for Early and Late Treatment
Valeria Pellegrini, Rosalba La Grotta, Francesca Carreras, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1662-1662
Open Access | Times Cited: 5
Effects of PARP1 inhibitor PJ-34 on TGFα, IL-6, and IL-1β levels in diabetic nephropathy
Jing Ke, Yanan Fan, Shaochun Zhang
The Journal of Immunology (2025)
Closed Access
Impact of sodium-glucose cotransporter-2 inhibitors on ovarian cancer risk in patients with type 2 diabetes mellitus: A multi-institutional TriNetX study
Cheng‐Hsien Hung, Jheng‐Yan Wu, Yueh‐Shan Weng, et al.
Diabetes Research and Clinical Practice (2025), pp. 112109-112109
Closed Access
Is it time to revise the fighting strategy toward type 2 diabetes? Sex and pollution as new risk factors
Michelangela Barbieri, Francesco Prattichizzo, Rosalba La Grotta, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102405-102405
Open Access | Times Cited: 4
Associations of three diagnostic glycemic measures with all-cause and cardiovascular mortality in people not on antidiabetic medications: A prospective cohort study
Jiayue Zhang, Weijia Zheng, Shuting Wang, et al.
Journal of Diabetes and its Complications (2025), pp. 108970-108970
Closed Access
Start small, think big: MicroRNAs in diabetes mellitus and relevant cardiorenal-liver metabolic health spectrum
Junren Chen, Meng Luo, Ziwei Xing, et al.
Metabolism (2025) Vol. 165, pp. 156153-156153
Closed Access
Separation, Purification, Structural Characterization, and In Vitro Hypoglycemic Activity of Polysaccharides from Panax notoginseng Leaves
X.-Q. Zhang, Chongying Shi, Zilin Wang, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 830-830
Open Access
Quercetin Intake and Absolute Telomere Length in Patients with Type 2 Diabetes Mellitus: Novel Findings from a Randomized Controlled Before-and-After Study
Aikaterini E. Mantadaki, Stella Baliou, Manolis Linardakis, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1136-1136
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top